Soluble tumor necrosis factor receptor treatment of medical disorders

摘要

The invention pertains to methods and compositions for reducing resistance to STI 571 in a chronic myelogenous leukemia patient by administering a TNFalpha inhibitor, such as recombinant TNFR:Fc to such patient.